{
  "Best_Efforts": {
    "regulatory_efforts": [
      {
        "section": "Best_Efforts",
        "field_name": "effort_standard",
        "answer": "Reasonable Best Efforts",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the parties will use their 'reasonable best efforts' to obtain regulatory approvals and satisfy conditions for the merger, which is a recognized standard in M&A agreements.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "effort_scope",
        "answer": "RBE for HSR and other applicable Antitrust Laws",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "regulatory_fillings_hsr": [
      {
        "section": "Best_Efforts",
        "field_name": "hsr_required",
        "answer": true,
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "hsr_filing_deadline_days",
        "answer": 25,
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "hsr_notes",
        "answer": "Must file within 25 Business Days following the date of this Agreement; filing required under HSR Act as a condition to closing.",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "regulatory_fillings_cfiius": [
      {
        "section": "Best_Efforts",
        "field_name": "cfiius_required",
        "answer": false,
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "cfiius_filing_deadline_days",
        "answer": "Not found",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "cfiius_notes",
        "answer": "Not found",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "regulatory_fillings_foreign": [
      {
        "section": "Best_Efforts",
        "field_name": "foreign_notes",
        "answer": "Foreign filings may be required under applicable non-U.S. laws",
        "confidence": 0.9,
        "reason": "The agreement mentions the need for filings under 'other applicable Antitrust Laws,' which implies that foreign antitrust or merger control filings may be necessary.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "foreign_required",
        "answer": true,
        "confidence": 0.9,
        "reason": "The agreement references obligations under 'other applicable Antitrust Laws' in Section 5.4, which implies that foreign filings are required.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "foreign_filing_deadline_days",
        "answer": "Not found",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "divestiture_commitments": [
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_required",
        "answer": true,
        "confidence": 0.9,
        "reason": "The agreement explicitly mentions that Parent, Merger Sub, and Parent's Subsidiaries shall take all necessary actions, including Remedy Actions such as selling, divesting, holding separate, leasing, licensing, transferring, disposing of, or otherwise encumbering assets, to eliminate impediments under any Antitrust Law and obtain necessary consents for the merger.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_target_value",
        "answer": 140,
        "confidence": 0.9,
        "reason": "The agreement specifies that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products of the Company that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year, indicating a divestiture cap based on this sales threshold.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_target_unit",
        "answer": "USD_millions",
        "confidence": 0.9,
        "reason": "The clause specifies a divestiture limitation based on net sales exceeding $140,000,000 during the Company's 2024 fiscal year, which implies a financial measure in USD millions.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_target_basis",
        "answer": "revenue",
        "confidence": 0.9,
        "reason": "The divestiture cap is implied to be based on 'net sales' as mentioned in the context of divestiture commitments, which is functionally equivalent to 'revenue'.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_target_basis_scope",
        "answer": "Target",
        "confidence": 0.8,
        "reason": "The divestiture cap is applied to businesses and products of the Company and its Subsidiaries, as indicated by the clause stating that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products of the Company and its Subsidiaries exceeding a certain sales threshold.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_target_notes",
        "answer": "Cap applies to Target units generating more than $140,000,000 in net sales during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause in Section 5.4(d) specifies that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products of the Company that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year, implying a divestiture cap based on this sales threshold.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_target_clause_reference",
        "answer": "Section 5.4(d)",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_buyer_value",
        "answer": 140000000,
        "confidence": 0.9,
        "reason": "The agreement specifies that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products of the Company and its Subsidiaries that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year, implying a divestiture cap at this value.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_buyer_unit",
        "answer": "Not found",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_buyer_basis",
        "answer": "Not found",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_buyer_basis_scope",
        "answer": "Parent",
        "confidence": 0.9,
        "reason": "The divestiture commitments section implies that the Buyer, referred to as Parent and its Subsidiaries, is responsible for divestiture actions, indicating that their operations or assets are within the scope of the divestiture cap.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_buyer_notes",
        "answer": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products of Parent and its Subsidiaries (other than, following the Closing, the Company and its Subsidiaries).",
        "confidence": 0.9,
        "reason": "The clause in Section 5.4(d) specifies that Parent is not required to take Remedy Actions with respect to its own businesses and products, which implies a limitation on the actions Parent must take.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_cap_buyer_clause_reference",
        "answer": "Section 5.4(d)",
        "confidence": 0.9,
        "reason": "The section outlines the obligations of Parent, Merger Sub, and Parent's Subsidiaries to take actions necessary to eliminate impediments under Antitrust Law, which implies divestiture commitments.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_scope_exclusions",
        "answer": [
          "businesses and products of the Company and its Subsidiaries that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year",
          "businesses and products of Parent and its Subsidiaries (other than, following the Closing, the Company and its Subsidiaries)"
        ],
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_clause_summary",
        "answer": "Not found",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "divestiture_clause_summary_clause_reference",
        "answer": "Section 5.4(d)",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "litigation_commitments": [
      {
        "section": "Best_Efforts",
        "field_name": "litigation_requirement_status",
        "answer": "Explicit Requirement to Litigate",
        "confidence": 0.9,
        "reason": "Section 5.4(d) requires Parent, Merger Sub, and Parent's Subsidiaries to defend through litigation any Proceeding that seeks to prevent, prohibit, interfere with, or delay the Closing, implying a duty to litigate to secure closing.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "litigation_clause_scope",
        "answer": "Litigate through appeals to eliminate impediments under Antitrust Law unless Remedy Actions exceed specified sales thresholds.",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "required_to_litigate_notes",
        "answer": "Parent must litigate regulatory challenges through appeals unless conditions to closing are impossible.",
        "confidence": 0.8,
        "reason": "The document states that Parent, Merger Sub, and Parent's Subsidiaries shall take all actions necessary to eliminate impediments under any Antitrust Law, including defending through litigation on the merits or otherwise, including appeals, any Proceeding that seeks to prevent, prohibit, interfere with or delay the Closing.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "withdrawal_and_timing_controls_withdrawal": [
      {
        "section": "Best_Efforts",
        "field_name": "withdrawal_control_type",
        "answer": "mutual_consent_required",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "withdrawal_control_type_notes",
        "answer": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "withdrawal_and_timing_controls_timing": [
      {
        "section": "Best_Efforts",
        "field_name": "timing_agreement_restriction",
        "answer": true,
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "timing_agreement_restriction_notes",
        "answer": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed. None of Parent, Merger Sub or the Company (including their respective Subsidiaries) shall, without the other party's prior written consent, enter into any timing or similar agreement, or otherwise agree or commit to any arrangement, that would have the effect of extending, suspending, lengthening or otherwise tolling the expiration or termination of any waiting period applicable to consummate the transactions contemplated by this Agreement under the HSR Act, such consent not to be unreasonably withheld, conditioned or delayed.",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "remedy_actions_other": [
      {
        "section": "Best_Efforts",
        "field_name": "remedy_definitions_provided",
        "answer": "true",
        "confidence": 0.9,
        "reason": "The term 'Remedy Action' is defined in Section 5.4(d) as actions required to eliminate impediments under Antitrust Law, including selling or divesting assets, which implies a definition.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "remedy_definition_text",
        "answer": "Divest, license, or take steps to satisfy regulator",
        "confidence": 0.9,
        "reason": "The term 'Remedy Action' is indirectly defined in Section 5.4(d) as actions required to eliminate impediments under Antitrust Law, including selling, divesting, holding separate, leasing, licensing, transferring, disposing of, or otherwise encumbering assets.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "remedy_definition_text_clause_reference",
        "answer": "Section 5.4(d)",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "transaction_interference": [
      {
        "section": "Best_Efforts",
        "field_name": "restriction_on_other_transactions",
        "answer": true,
        "confidence": 0.9,
        "reason": "The agreement includes restrictions on the Company from soliciting or pursuing alternative transactions that could interfere with the merger, as seen in Section 5.6(a), which prohibits the Company from engaging in activities related to Acquisition Proposals.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "interference_clause_text",
        "answer": "sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "interference_clause_text_clause_reference",
        "answer": "Section 5.4",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "second_request_certification": [
      {
        "section": "Best_Efforts",
        "field_name": "deadline_specified",
        "answer": false,
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "certification_timeline_notes",
        "answer": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "confidence": 0.9,
        "reason": "The agreement specifies a timeline for making HSR Act filings, stating that they must be made as promptly as reasonably practicable and no later than 25 business days following the date of the agreement.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "certification_responsibility_party",
        "answer": "Both",
        "confidence": 0.9,
        "reason": "The agreement specifies that both parties will cooperate and use their reasonable best efforts to make necessary filings under the HSR Act, implying joint responsibility for certifying compliance.",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "ftc_warning_letter_handling": [
      {
        "section": "Best_Efforts",
        "field_name": "addressed",
        "answer": "false",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "handling_notes",
        "answer": "Not addressed",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "effect_on_closing_condition",
        "answer": "Silent",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      },
      {
        "section": "Best_Efforts",
        "field_name": "addressed_notes",
        "answer": "Not found",
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ],
    "other_timing_controls": [
      {
        "section": "Best_Efforts",
        "field_name": "other_timing_controls.other_deadlines_specified",
        "answer": [
          "Company Stockholders' Meeting to occur within 50 days of F-4 effectiveness",
          "Adjournments or postponements of the Company Stockholders' Meeting without Parent's consent shall be for a period of no more than 25 Business Days in the aggregate"
        ],
        "confidence": 1.0,
        "reason": "",
        "categories_used": [
          "Covenants  >  Efforts",
          "Covenants  >  Conduct of Business",
          "Covenants  >  Financing Cooperation"
        ]
      }
    ]
  }
}
